Connect public, paid and private patent data with Google Patents Public Datasets

Hydrogels

Info

Publication number
WO1997041900A1
WO1997041900A1 PCT/GB1997/001244 GB9701244W WO1997041900A1 WO 1997041900 A1 WO1997041900 A1 WO 1997041900A1 GB 9701244 W GB9701244 W GB 9701244W WO 1997041900 A1 WO1997041900 A1 WO 1997041900A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
hydrogel
structure
precursor
method
fibrous
Prior art date
Application number
PCT/GB1997/001244
Other languages
French (fr)
Inventor
Denis Keith Gilding
Yimin Qin
Original Assignee
Innovative Technologies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913Rod, strand, filament or fiber
    • Y10T428/2973Particular cross section
    • Y10T428/2978Surface characteristic

Abstract

A method of producing a hydrogel product comprises impregnating a coherent fibrous structure with an aqueous solution of a hydrogel precursor material, said fibres incorporating cations which are capable of cross-linking said precursor material to form a fibre reinforced hydrogel as the hydrogel product.

Description

HYDROGELS

The present invention relates to hydrogels, i.e. cross-linked macromolecular networks which are swollen with water or biological fluids. The invention relates more particularly, but not exclusively, to such hydrogels that are useful as wound dressings.

A hydrogel is a cross-linked macromolecular network swollen with water or biological fluids. It is known that hydrogels are useful as wound dressings, particularly because of their ability to donate fluid to a wound to maintain a moist "healing environment". There are however disadvantages with prior art hydrogel dressings (e.g. Clearsile) in that they can be weak and difficult to handle.

It is therefore an object of the present invention to obviate or mitigate the above disadvantages.

According to a first aspect of the present invention there is provided a method of producing a hydrogel product comprising impregnating a coherent fibrous structure (preferably sterilised) with an aqueous solution of a hydrogel precursor material (preferably sterilised), said fibres incorporating cations which are capable of cross- linking said precursor material to form a fibre reinforced hydrogel as the hydrogel product.

By "coherent fibrous structure" we mean that the fibrous structure is comprised of fibres which are positively held together to maintain the overall coherency of the structure although obviously we do not preclude the possibility that individual fibres of the structure may become loose and detached. Such structures are to be distinguished from, for example, loose chopped fibres in which there is no mechanical forces holding the fibres together into the form of a structure. Examples of coherent fibrous structures which may be used in accordance with the invention are knitted, woven, and non-woven products such as felts, matts and the like. A preferred fibrous structure is a non-woven felt. A particularly preferred fibrous structure is a non-woven felt made of calcium alginate fibres and having a basis weight of 30 to 200 gsm, more preferably 40 to 80 gsm, and most preferably about 60 gsm.

The method of the invention is effected by impregnating the fibrous structure with the solution of hydrogel precursor, preferably in ratio (by weight) of solution-fabric of (20-70): 1. The method results in the production of a hydrogel which has been cross-linked (i.e. "set") by ions released from the fibres. In the final hydrogel the fibrous structure provides, in effect, a reinforcement giving strength for easy handling ofthe hydrogel. If desired the hydrogel product may be autoclaved.

Hydrogels produced in accordance with the invention may be in the form of sheets typically having a thickness of 1 mm to 10 mm.

The hydrogels are in a hydrated form and are capable of donating moisture to a wound. The hydrogels may be used for treating superficial wounds with low to medium levels of exudates

Examples of hydrogel precursor material which may be used include sodium alginate, sodium carboxymethyl cellulose, sodium pectinate, sodium O- carboxymethyl chitosan (OCC), sodium N,0-carboxymethyl chitosan (NOCC). sodium polyacrylate, and naturally occurring gums and synthetic polymers containing pendant carboxylic acid groups (hummectants).

The hydrogel precursor may consist wholly or partially of Ace Mannan (or other component of Alloe Vera) which is a natural polymer known to accelerate healing of wounds. The Ace Mannan may, for example, provide up to 80% of the matrix. The Ace Mannan may be clinical grade material obtainable from Carrington Laboratories, Dallas, Texas, U.S.A.

The hydrogel precursor may, if desired, incorporate an agent lo stimulate the healing of wounds. Examples of such agents include growth factors, e.g. whey growth factor extract (obtainable from GroPep Ltd. Australia) or Prczatidc copper acetate complex (obtainable from Procyte, U.S.A.).

The fibres which are used contain a di- or higher valent cation which is effective for cross-linking the hydrogel. Examples of suitable cations include Ca , Zn , and cations which also act as enzyme cofactors. Particular preferred examples of fibres which may be used are calcium alginate fibres.

Preferably the hydrogel precursor solution incorporates a bacteriostatic agent, preferably propylene glycol.

In a preferred method of carrying out the invention, the hydrogel precursor (e.g. an alginate) is dissolved in a mixture of 75%-85% by weight water and 15%> to 25% by weight propylene glycol. The resultant solution is then used to impregnate the coherent fibrous structure to form the hydrogel.

It is possible for the hydrogel precursor solution and coherent fibrous structure to be supplied separately whereby the method of the first aspect of the invention may¬ be effected in, for example, a surgery. This affords the possibility of either using the coherent fibrous structure as a dressing per se or using it to produce a hydrogel product as discussed above.

Therefore according to a second aspect of the invention there is provided a kit of parts for producing a hydrogel product, the kit comprising a container of a hydrogel precursor solution (preferably sterilised) and a coherent fibrous structure (preferably sterilised).

Hydrogel products obtained in accordance with the invention may be used in conjunction with hydrophilic films which have an increased breathability in the presence of liquid water as compared to moisture vapour alone. The use of such a film over the hydrogel (i.e. on the side remote from the wound) ensures that water is vented from the hydrogel through the film. Therefore the dissolution of the hydrogel may be controlled.

Typically the breathable film will be of a material which, as a 50 micron film, has an MVTR in the presence of moisture vapour alone of 6,000 to 10,000 g m 24hr as measured by ASTM E96B and an MVTR in the presence of a liquid water (as measured by ASTM E96BW) of 6.000 to 10,000 g m"2 24hr"' . Typically the breathable film will have a thickness of 30-70 microns, more preferably 40-60 microns, e.g. about 50 microns. The breathable film may for example be of polyurethane. Suitable films are available from Innovative Technologies Limited under the designations IT325, IT425 and IT625.

The invention is illustrated with reference to the following non-limiting Example.

Example

A none-woven felt made of calcium alginate Ml' 1 -2 A felt, available from Innovative Technologies) having a weight/unit area of about 60 g/m" was treated with a 2% alginate (Protanol LF 10/60, ex-Pronava) dissolved in a 80/20 mixture of water and propylene glycol. The ratio of solution to felt was 40 to 1 . The solution was first spread out in a flat stainless steel dish having a size of about 30 cm x 30 cm and the felt was then placed in solution. The fibres interacted with the sodium alginate in the solution to form a sheet hydrogel. The resultant gel could be autoclaved to provide a hydrated sheet hydrogel for treating superficial wounds with low to medium level of exudate.

Claims

1. A method of producing a hydrogel product comprising impregnating a coherent fibrous structure with an aqueous solution of a hydrogel precursor material, said fibres incoφorating cations which are capable of cross-linking said precursor material to form a fibre reinforced hydrogel as the hydrogel product.
2. A method as claimed in claim 1 wherein the coherent fibre structure is a knitted, woven or non-woven product.
3. A method as claimed in claim 2 wherein the coherent fibre structure is a felt or matt.
4. A method as claimed in any one of claims 1 to 3 wherein the hydrogel precursor is sodium alginate, sodium carboxymethyl cellulose, sodium pectinate, sodium O-carboxymethyl chitosan (OCC), sodium N, O-carboxymethyl chitosan (NOCC), sodium polyacrylate, and naturally occurring gums and synthetic polymers containing pendant carboxylic acid groups (hummectants).
5. A method as claimed in any one of claims 1 to 3 wherein the hydrogel precursor consists wholly or partially of Ace Mannan (or other component of Alloc Vera).
6. A method as claimed in any one of claims 1 to 5 wherein the hydrogel precursor incorporates an agent to stimulate the healing of wounds.
7. A method as claimed in any one of claims 1 to 6 wherein said cations are Ca ,
Zn and/or cations which also act as enzyme cofactors.
8. A method as claimed in any one of the preceding claims wherein the fibres are calcium alginate fibres.
9. A method as claimed in any one of the preceding claims wherein the hydrogel precursor is dissolved in a mixture of 75% to 85%> by weight water and 15% to 25% by weight propylene glycol.
10. A method as claimed in any one of the preceding claims wherein the ratio by volume of the hydrogel precursor solution to the coherent fibre structure is (20 to 70): 1.
1 1. A hydrogel product which comprises a hydrogel and a reinforcement of a fibrous structure which is coherent per se.
12. A hydrogel product as produced by the method of any one of claims 1 to 10 or as claimed in claim 1 1 for use as a primary wound dressing for superficial wounds with low to medium levels of exudate.
13. A kit of parts for producing a hydrogel product, the kit comprising a container of a hydrogel precursor solution (preferably sterilised ) and a coherent fibrous structure (preferably sterilised).
PCT/GB1997/001244 1996-05-08 1997-05-08 Hydrogels WO1997041900A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9609474A GB9609474D0 (en) 1996-05-08 1996-05-08 Hydrogels
GB9609474.3 1996-05-08

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE1997627801 DE69727801D1 (en) 1996-05-08 1997-05-08 Fiber-reinforced hydrogel
EP19970920851 EP0901382B1 (en) 1996-05-08 1997-05-08 Reinforced hydrogels
JP53966097A JP2000510718A (en) 1996-05-08 1997-05-08 Hydrogel
US09180171 US6534083B2 (en) 1996-05-08 1997-05-08 Hydrogels
DE1997627801 DE69727801T2 (en) 1996-05-08 1997-05-08 Fiber-reinforced hydrogel

Publications (1)

Publication Number Publication Date
WO1997041900A1 true true WO1997041900A1 (en) 1997-11-13

Family

ID=10793283

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/001244 WO1997041900A1 (en) 1996-05-08 1997-05-08 Hydrogels

Country Status (7)

Country Link
US (1) US6534083B2 (en)
JP (1) JP2000510718A (en)
DE (2) DE69727801D1 (en)
EP (1) EP0901382B1 (en)
ES (1) ES2215226T3 (en)
GB (1) GB9609474D0 (en)
WO (1) WO1997041900A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102425A2 (en) * 2001-06-20 2002-12-27 Panayiotis Spyros Spyropoulos Compound hydrogel wound dressing
EP1607412A1 (en) * 2004-06-07 2005-12-21 First Water Limited Hydrogel Composites
US6998509B1 (en) 1999-10-07 2006-02-14 Coloplast A/S Wound care device
EP2253665A1 (en) 2009-04-22 2010-11-24 Dr. Suwelack Skin & Health Care AG Freeze-dried composition
WO2010140146A2 (en) 2009-06-01 2010-12-09 Technion - Research & Development Foundation Ltd Sealants, manufacturing thereof, and applications thereof
JP2012006971A (en) * 1999-12-09 2012-01-12 Apimed Medical Honey Ltd Honey based medical dressing
US8377241B2 (en) 2005-07-29 2013-02-19 W. L. Gore & Associates, Inc. Method of making porous self-cohered web materials
US8597745B2 (en) 2005-07-29 2013-12-03 W. L. Gore & Associates, Inc. Composite self-cohered web materials
US8673354B2 (en) 2007-11-05 2014-03-18 Technion Research And Development Foundation Ltd. Adhesives and methods of applying the same
WO2014057254A1 (en) * 2012-10-08 2014-04-17 First Water Limited Hydrogel composites

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946585B2 (en) * 2000-10-23 2005-09-20 Mcneil-Ppc, Inc. Absorbent article
NL1023924C2 (en) * 2003-07-15 2005-01-18 Stichting Tech Wetenschapp Tissue Replacement material.
WO2005023323A1 (en) * 2003-09-08 2005-03-17 Fmc Biopolymer As Gelled biopolymer based foam
EP1799232B1 (en) 2004-10-12 2015-10-07 FMC Biopolymer AS Self-gelling alginate systems and uses thereof
US20060263415A1 (en) 2005-05-05 2006-11-23 Sensient Flavors Inc. Production of beta-glucans and mannans
US20070026039A1 (en) * 2005-07-29 2007-02-01 Drumheller Paul D Composite self-cohered web materials
EP2192906A4 (en) * 2007-08-28 2014-10-29 Fmc Corp Delayed self-gelling alginate systems and uses thereof
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
EP2498764B1 (en) 2009-11-09 2017-09-06 Spotlight Technology Partners LLC Fragmented hydrogels

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012471A1 (en) * 1988-06-24 1989-12-28 Britcair Limited Wound dressing
GB2221620A (en) * 1988-07-29 1990-02-14 Johnson & Johnson Patient Care Haemostatic wound dressing material
WO1990014110A1 (en) * 1989-05-16 1990-11-29 Jean Vilain Improvements in or relating to pharmaceutical preparations
WO1995019795A1 (en) * 1994-01-20 1995-07-27 Bristol-Myers Squibb Company Wound dressing
EP0666081A1 (en) * 1994-01-24 1995-08-09 Bristol-Myers Squibb Company Wound dressing
WO1996010106A1 (en) * 1994-09-29 1996-04-04 Innovative Technologies Limited Fibres
WO1996013285A1 (en) * 1994-10-28 1996-05-09 Innovative Technologies Limited Dehydrated hydrogels
WO1996013282A1 (en) * 1994-10-27 1996-05-09 Innovative Technologies Limited Wound dressing
WO1997003710A1 (en) * 1995-07-19 1997-02-06 Innovative Technologies Limited Wound treatment composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227955A3 (en) * 1982-07-21 1987-11-25 University of Strathclyde Composite wound dressing
US4548847A (en) * 1984-01-09 1985-10-22 Kimberly-Clark Corporation Delayed-swelling absorbent systems
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US5210117A (en) * 1990-03-27 1993-05-11 Korea Research Institute Of Chemical Technology Resin composition having biodegradability and high absorbency, nonwoven fabric made of the same and pads comprising said fabric
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6171610B1 (en) * 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
GB0200838D0 (en) * 2002-01-15 2002-03-06 Xchangepoint Holdings Ltd Virtual local area network interconnection

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012471A1 (en) * 1988-06-24 1989-12-28 Britcair Limited Wound dressing
GB2221620A (en) * 1988-07-29 1990-02-14 Johnson & Johnson Patient Care Haemostatic wound dressing material
WO1990014110A1 (en) * 1989-05-16 1990-11-29 Jean Vilain Improvements in or relating to pharmaceutical preparations
WO1995019795A1 (en) * 1994-01-20 1995-07-27 Bristol-Myers Squibb Company Wound dressing
EP0666081A1 (en) * 1994-01-24 1995-08-09 Bristol-Myers Squibb Company Wound dressing
WO1996010106A1 (en) * 1994-09-29 1996-04-04 Innovative Technologies Limited Fibres
WO1996013282A1 (en) * 1994-10-27 1996-05-09 Innovative Technologies Limited Wound dressing
WO1996013285A1 (en) * 1994-10-28 1996-05-09 Innovative Technologies Limited Dehydrated hydrogels
WO1997003710A1 (en) * 1995-07-19 1997-02-06 Innovative Technologies Limited Wound treatment composition

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998509B1 (en) 1999-10-07 2006-02-14 Coloplast A/S Wound care device
US7141714B2 (en) 1999-10-07 2006-11-28 Coloplast A/S Wound care device
JP2012006971A (en) * 1999-12-09 2012-01-12 Apimed Medical Honey Ltd Honey based medical dressing
WO2002102425A3 (en) * 2001-06-20 2007-11-08 Panayiotis Spyros Spyropoulos Compound hydrogel wound dressing
WO2002102425A2 (en) * 2001-06-20 2002-12-27 Panayiotis Spyros Spyropoulos Compound hydrogel wound dressing
EP1607412A1 (en) * 2004-06-07 2005-12-21 First Water Limited Hydrogel Composites
US8377241B2 (en) 2005-07-29 2013-02-19 W. L. Gore & Associates, Inc. Method of making porous self-cohered web materials
US8597745B2 (en) 2005-07-29 2013-12-03 W. L. Gore & Associates, Inc. Composite self-cohered web materials
US8673354B2 (en) 2007-11-05 2014-03-18 Technion Research And Development Foundation Ltd. Adhesives and methods of applying the same
EP2253665A1 (en) 2009-04-22 2010-11-24 Dr. Suwelack Skin & Health Care AG Freeze-dried composition
WO2010140146A2 (en) 2009-06-01 2010-12-09 Technion - Research & Development Foundation Ltd Sealants, manufacturing thereof, and applications thereof
EP2638922A1 (en) 2009-06-01 2013-09-18 Technion Research & Development Foundation Ltd. Multi-components adhesives, manufacturing thereof, and applications thereof
US9216234B2 (en) 2009-06-01 2015-12-22 Technion Research & Development Foundation Ltd. Sealants, manufacturing thereof, and application thereof
WO2014057254A1 (en) * 2012-10-08 2014-04-17 First Water Limited Hydrogel composites

Also Published As

Publication number Publication date Type
DE69727801T2 (en) 2004-12-02 grant
JP2000510718A (en) 2000-08-22 application
DE69727801D1 (en) 2004-04-01 grant
US20020009591A1 (en) 2002-01-24 application
GB9609474D0 (en) 1996-07-10 grant
EP0901382B1 (en) 2004-02-25 grant
ES2215226T3 (en) 2004-10-01 grant
US6534083B2 (en) 2003-03-18 grant
EP0901382A1 (en) 1999-03-17 application

Similar Documents

Publication Publication Date Title
US5977428A (en) Absorbent hydrogel particles and use thereof in wound dressings
Corkhill et al. Synthetic hydrogels VI. Hydrogel composites as wound dressings and implant materials
US4960413A (en) Wound dressing
Kannon et al. Moist wound healing with occlusive dressings
US4412947A (en) Collagen sponge
US5238685A (en) Wound dressing
US4699135A (en) Shaped chitin body
US5836970A (en) Hemostatic wound dressing
US4225580A (en) Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
US4655758A (en) Microbial polysaccharide articles and methods of production
US5470576A (en) Process for preparing the alginate-containing wound dressing
Walker et al. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethyl cellulose (AQUACEL®) and alginate dressings
US5735812A (en) Water soluble wound dressing materials
US5135472A (en) Non-linting composite gauze material
US3823212A (en) Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US5584801A (en) Wound covering
US20060172000A1 (en) Compositions for wound treatment
US6372248B1 (en) Dehydrated hydrogels
US6565878B2 (en) Method for preparing a non-fibrous porous material
EP0091800A1 (en) Surgical adhesive dressing
US5658582A (en) Multilayer nonwoven tissue containing a surface layer comprising at least one hyaluronic acid ester
US5941840A (en) Multi-layered wound dressing
WO1996013282A1 (en) Wound dressing
US5738860A (en) Non-fibrous porous material, wound dressing and method of making the material
US20040236260A1 (en) Multi-layered wound dressing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997920851

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997920851

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09180171

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1997920851

Country of ref document: EP